Correlation Between Checkpoint Therapeutics and Collplant Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Collplant Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Collplant Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Checkpoint Therapeutics and Collplant Biotechnologies, you can compare the effects of market volatilities on Checkpoint Therapeutics and Collplant Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Collplant Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Collplant Biotechnologies.
Diversification Opportunities for Checkpoint Therapeutics and Collplant Biotechnologies
-0.86 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Checkpoint and Collplant is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Collplant Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collplant Biotechnologies and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Collplant Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collplant Biotechnologies has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Collplant Biotechnologies go up and down completely randomly.
Pair Corralation between Checkpoint Therapeutics and Collplant Biotechnologies
Given the investment horizon of 90 days Checkpoint Therapeutics is expected to generate 1.43 times more return on investment than Collplant Biotechnologies. However, Checkpoint Therapeutics is 1.43 times more volatile than Collplant Biotechnologies. It trades about 0.04 of its potential returns per unit of risk. Collplant Biotechnologies is currently generating about -0.01 per unit of risk. If you would invest 372.00 in Checkpoint Therapeutics on August 30, 2024 and sell it today you would earn a total of 56.00 from holding Checkpoint Therapeutics or generate 15.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Checkpoint Therapeutics vs. Collplant Biotechnologies
Performance |
| Timeline |
| Checkpoint Therapeutics |
| Collplant Biotechnologies |
Checkpoint Therapeutics and Collplant Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Checkpoint Therapeutics and Collplant Biotechnologies
The main advantage of trading using opposite Checkpoint Therapeutics and Collplant Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Collplant Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will offset losses from the drop in Collplant Biotechnologies' long position.| Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
| Collplant Biotechnologies vs. Keros Therapeutics | Collplant Biotechnologies vs. Merus BV | Collplant Biotechnologies vs. Vericel Corp Ord | Collplant Biotechnologies vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |